BMS at EADV 2021

Intended for U.S. scientific audiences only.

The European Academy of Dermatology and Venereology (EADV) serves as an important exchange of scientific breakthroughs and research for physicians and patients living with serious dermatologic diseases. We look forward to presenting new research and sharing our progress advancing pathbreaking science with the hope of providing truly meaningful solutions for patients in need.

Samit Hirawat on BMS’ leadership in dermatology

Hear from our chief medical officer of Global Drug Development, Samit Hirawat, M.D., about how we are advancing pathbreaking science with the goal of providing truly meaningful solutions for people with immune-mediated diseases.

Our Data at EADV 2021

Read more about our key data being presented at the meeting.

At EADV 2021, Bristol Myers Squibb is presenting data on an investigational compound in psoriasis as well as the company’s broader dermatology research and pipeline.

Scientific Innovations Driving Meaningful Advancements Forward

We are committed to improving the lives of patients with immune-mediated diseases, like psoriasis, psoriatic arthritis and atopic dermatitis, and remain steadfast in exploring additional potential treatment options that might provide benefit for patients where unmet need still exists. Learn more below.

Pioneering New Paths Forward in Psoriasis >

Renata Kisa, worldwide medical lead, Dermatology, provides insight into the current unmet needs for patients with psoriasis, and explores the need for differentiated treatment options.

Destination: The Impact of Precision Medicine in Disease Management for People with Immune-Mediated Diseases >

Brian Gavin, development lead, discusses Bristol Myers Squibb’s approach to unlocking the full potential of precision medicine for immune-mediated diseases.

Pursuing Innovative Approaches to Advance Research for Psoriatic Disease >

Shalabh Singhal, executive director, development program lead, Rheumatology, explains how by targeting the tyrosine kinase 2 (TYK2) pathway, researchers can further our understanding of how to improve care for psoriatic disease.


Our research in Immunology and dermatology follows a science-driven pathway approach that delivers scientific innovation across key areas of focus.

TYK2 Pathway Fact Sheet >

Learn about the scientific mechanism behind the TYK2 pathway and its role in immune-mediated diseases.

Learn about the TYK2 pathway and its role in immune-mediated diseases like psoriasis. is a resource for U.S. healthcare professionals to learn more about our recruiting clinical trials as well as the breadth of our research. 

Atopic Dermatitis >

Learn more about atopic dermatitis, its symptoms and its potential impact on patients.

Psoriasis >

Learn more about psoriasis, its symptoms and potential impact on patients.

Psoriatic Arthritis >

Learn more about psoriatic arthritis, its symptoms and its potential impact on patients.